Cargando…
First person – Sarah Woodfield
First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping early-career researchers promote themselves alongside their papers. Sarah Woodfield is first author on ‘ HepT1-derived murine models of high-risk hepatoblastoma display vascular...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326489/ http://dx.doi.org/10.1242/bio.059367 |
_version_ | 1784757298034376704 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping early-career researchers promote themselves alongside their papers. Sarah Woodfield is first author on ‘ HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells’, published in BiO. Sarah is assistant professor of surgery at Baylor College of Medicine and the Texas Children's Hospital in Houston, investigating the high-risk features of hepatoblastoma, including primarily metastasis and chemoresistance, with the overall goal of better understanding these characteristics in order to target them with novel inhibitors to improve patient outcomes. |
format | Online Article Text |
id | pubmed-9326489 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-93264892022-08-01 First person – Sarah Woodfield Biol Open First Person First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping early-career researchers promote themselves alongside their papers. Sarah Woodfield is first author on ‘ HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells’, published in BiO. Sarah is assistant professor of surgery at Baylor College of Medicine and the Texas Children's Hospital in Houston, investigating the high-risk features of hepatoblastoma, including primarily metastasis and chemoresistance, with the overall goal of better understanding these characteristics in order to target them with novel inhibitors to improve patient outcomes. The Company of Biologists Ltd 2022-09-13 /pmc/articles/PMC9326489/ http://dx.doi.org/10.1242/bio.059367 Text en © 2022. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Sarah Woodfield |
title | First person – Sarah Woodfield |
title_full | First person – Sarah Woodfield |
title_fullStr | First person – Sarah Woodfield |
title_full_unstemmed | First person – Sarah Woodfield |
title_short | First person – Sarah Woodfield |
title_sort | first person – sarah woodfield |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326489/ http://dx.doi.org/10.1242/bio.059367 |